RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Palantir Bioceuticals Stock

Palantir Bioceuticals Stocks 2025

Palantir Bioceuticals Stocks

82.48 M

Ticker

IFAN

ISIN

US45173B1017

WKN

A12GSL

In 2025, Palantir Bioceuticals had 82.48 M outstanding stocks, a 0% change from the 82.48 M stocks in the previous year.

The Palantir Bioceuticals Stocks history

YEARNUMBER OF STOCKS (undefined USD)
20220.08
20210.08
20150.08
20140.72
20131.02
20121.42
20111.42
20101.42

Palantir Bioceuticals shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Palantir Bioceuticals earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Palantir Bioceuticals's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Palantir Bioceuticals’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Palantir Bioceuticals's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Palantir Bioceuticals Aktienanalyse

What does Palantir Bioceuticals do?

IFAN Financial Inc is a company based in Las Vegas, Nevada. It originated in 1998 with the founding of iCARD Systems, specializing in prepaid cards. In 2007, the company changed its name to IFAN Financial Inc and expanded its business. The business model of IFAN Financial Inc focuses on providing financial services and technologies. The company specializes in various fields, including payment processing, mobile payment solutions, e-commerce, point-of-sale systems, and ethical investments. One important division of the company is IFAN Payment Systems, which offers a wide range of payment processing and payment solutions. The solutions can be used both online and offline. One particular feature is that IFAN Payment Systems provides fast transaction processing while maintaining high security standards. IFAN Financial Inc also has a division in the mobile services sector, which includes providing mobile payment solutions and mobile banking services. These services can be accessed through mobile devices and are tailored to the needs of modern customers who use mobile devices to manage and monitor their finances. Another important area in which IFAN Financial Inc operates is e-commerce. The focus is on providing technical solutions that allow customers to securely and effectively buy and sell goods and services online. The company has also developed a solution for online marketplaces, making it easier for merchants to register and sell on multiple platforms. The point-of-sale solutions of IFAN Financial Inc enable secure payments at retail terminals. The company offers a wide range of products, including POS hardware and POS software. These solutions are particularly designed to speed up transaction processing and increase customer satisfaction. Another important aspect of the company is ethical investing. IFAN Financial Inc advocates for ethical investments that have profit-oriented goals but do not come at the expense of other people or the environment. The company identifies investments that align with its portfolio of ethical investment products. Overall, IFAN Financial Inc has a wide portfolio of services and products tailored to the needs of customers. The company strives to provide customers with a secure and effective payment system that helps them manage their finances and optimize their businesses. The company has been in business since 1998 and thus has extensive experience in the financial sector. Palantir Bioceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Palantir Bioceuticals's Shares Outstanding

Palantir Bioceuticals's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Palantir Bioceuticals’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Palantir Bioceuticals’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Palantir Bioceuticals’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Palantir Bioceuticals stock

How many stocks are there of Palantir Bioceuticals?

The current number of stocks of Palantir Bioceuticals is 82.48 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Palantir Bioceuticals are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Palantir Bioceuticals evolved in recent years?

The number of shares of Palantir Bioceuticals has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Palantir Bioceuticals as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Palantir Bioceuticals?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Palantir Bioceuticals pay?

Over the past 12 months, Palantir Bioceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Palantir Bioceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Palantir Bioceuticals?

The current dividend yield of Palantir Bioceuticals is .

When does Palantir Bioceuticals pay dividends?

Palantir Bioceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Palantir Bioceuticals?

Palantir Bioceuticals paid dividends every year for the past 0 years.

What is the dividend of Palantir Bioceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Palantir Bioceuticals located?

Palantir Bioceuticals is assigned to the '-' sector.

Wann musste ich die Aktien von Palantir Bioceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Palantir Bioceuticals from 8/3/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/3/2025.

When did Palantir Bioceuticals pay the last dividend?

The last dividend was paid out on 8/3/2025.

What was the dividend of Palantir Bioceuticals in the year 2024?

In the year 2024, Palantir Bioceuticals distributed 0 USD as dividends.

In which currency does Palantir Bioceuticals pay out the dividend?

The dividends of Palantir Bioceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Palantir Bioceuticals

Our stock analysis for Palantir Bioceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Palantir Bioceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.